These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 25037562)

  • 1. Kidney function and population-based outcomes of initiating oral atenolol versus metoprolol tartrate in older adults.
    Fleet JL; Weir MA; McArthur E; Ozair S; Devereaux PJ; Roberts MA; Jain AK; Garg AX
    Am J Kidney Dis; 2014 Dec; 64(6):883-91. PubMed ID: 25037562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapy: atenolol versus metoprolol tartrate--conflicting outcomes data.
    Randhawa SK; Elliott WJ
    Nat Rev Nephrol; 2014 Nov; 10(11):617-8. PubMed ID: 25201142
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparative effectiveness of beta-adrenergic antagonists (atenolol, metoprolol tartrate, carvedilol) on the risk of rehospitalization in adults with heart failure.
    Go AS; Yang J; Gurwitz JH; Hsu J; Lane K; Platt R
    Am J Cardiol; 2007 Aug; 100(4):690-6. PubMed ID: 17697830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dosing errors in prescribed antibiotics for older persons with CKD: a retrospective time series analysis.
    Farag A; Garg AX; Li L; Jain AK
    Am J Kidney Dis; 2014 Mar; 63(3):422-8. PubMed ID: 24189475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kidney, Cardiac, and Safety Outcomes Associated With α-Blockers in Patients With CKD: A Population-Based Cohort Study.
    Hundemer GL; Knoll GA; Petrcich W; Hiremath S; Ruzicka M; Burns KD; Edwards C; Bugeja A; Rhodes E; Sood MM
    Am J Kidney Dis; 2021 Feb; 77(2):178-189.e1. PubMed ID: 32920153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atenolol is associated with lower day-of-surgery heart rate compared to long- and short-acting metoprolol.
    Schonberger RB; Brandt C; Feinleib J; Dai F; Burg MM
    J Cardiothorac Vasc Anesth; 2013 Apr; 27(2):298-304. PubMed ID: 22889605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effectiveness of metoprolol versus atenolol on prevention of all-cause and cardiovascular mortality in a large Chinese population: a cohort study.
    Wong MC; Tam WW; Lao XQ; Wang HH; Kwan MW; Cheung CS; Tong EL; Cheung NT; Yan BP; Yu CM; Griffiths SM
    Int J Cardiol; 2014 Aug; 175(3):425-32. PubMed ID: 24986230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective β1-antagonism with bisoprolol is associated with fewer postoperative strokes than atenolol or metoprolol: a single-center cohort study of 44,092 consecutive patients.
    Ashes C; Judelman S; Wijeysundera DN; Tait G; Mazer CD; Hare GM; Beattie WS
    Anesthesiology; 2013 Oct; 119(4):777-87. PubMed ID: 23820187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased risk of mortality in the elderly population with late-stage chronic kidney disease: a cohort study in Taiwan.
    Hwang SJ; Lin MY; Chen HC; Hwang SC; Yang WC; Hsu CC; Chiu HC; Mau LW
    Nephrol Dial Transplant; 2008 Oct; 23(10):3192-8. PubMed ID: 18450830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short-term change in kidney function and risk of end-stage renal disease.
    Turin TC; Coresh J; Tonelli M; Stevens PE; de Jong PE; Farmer CK; Matsushita K; Hemmelgarn BR
    Nephrol Dial Transplant; 2012 Oct; 27(10):3835-43. PubMed ID: 22764191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Comparative Study of Carvedilol Versus Metoprolol Initiation and 1-Year Mortality Among Individuals Receiving Maintenance Hemodialysis.
    Assimon MM; Brookhart MA; Fine JP; Heiss G; Layton JB; Flythe JE
    Am J Kidney Dis; 2018 Sep; 72(3):337-348. PubMed ID: 29653770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative effectiveness of different beta-adrenergic antagonists on mortality among adults with heart failure in clinical practice.
    Go AS; Yang J; Gurwitz JH; Hsu J; Lane K; Platt R
    Arch Intern Med; 2008 Dec; 168(22):2415-21. PubMed ID: 19064823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GFR decline and subsequent risk of established kidney outcomes: a meta-analysis of 37 randomized controlled trials.
    Lambers Heerspink HJ; Tighiouart H; Sang Y; Ballew S; Mondal H; Matsushita K; Coresh J; Levey AS; Inker LA
    Am J Kidney Dis; 2014 Dec; 64(6):860-6. PubMed ID: 25441439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beta blockers for elective surgery in elderly patients: population based, retrospective cohort study.
    Redelmeier D; Scales D; Kopp A
    BMJ; 2005 Oct; 331(7522):932. PubMed ID: 16210252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. β-Blocker Use and Risk of Mortality in Heart Failure Patients Initiating Maintenance Dialysis.
    Zhou H; Sim JJ; Shi J; Shaw SF; Lee MS; Neyer JR; Kovesdy CP; Kalantar-Zadeh K; Jacobsen SJ
    Am J Kidney Dis; 2021 May; 77(5):704-712. PubMed ID: 33010357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential effects of metoprolol and atenolol to neuropeptide Y blockade in coronary artery disease.
    Gullestad L; Pernow J; Bjurö T; Aaberge L; Skårdal R; Kjekshus E; Høglund L; Mellgård AJ; Wahlquist I; Ablad B
    Scand Cardiovasc J; 2012 Feb; 46(1):23-31. PubMed ID: 22017530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potentially preventable hospitalization as a complication of CKD: a cohort study.
    Wiebe N; Klarenbach SW; Allan GM; Manns BJ; Pelletier R; James MT; Bello A; Hemmelgarn BR; Tonelli M;
    Am J Kidney Dis; 2014 Aug; 64(2):230-8. PubMed ID: 24731738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The influence of renal function on clinical outcome and response to beta-blockade in systolic heart failure: insights from Metoprolol CR/XL Randomized Intervention Trial in Chronic HF (MERIT-HF).
    Ghali JK; Wikstrand J; Van Veldhuisen DJ; Fagerberg B; Goldstein S; Hjalmarson A; Johansson P; Kjekshus J; Ohlsson L; Samuelsson O; Waagstein F; Wedel H;
    J Card Fail; 2009 May; 15(4):310-8. PubMed ID: 19398079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incident Atrial Fibrillation and the Risk of Congestive Heart Failure, Myocardial Infarction, End-Stage Kidney Disease, and Mortality Among Patients With a Decreased Estimated GFR.
    Massicotte-Azarniouch D; Kuwornu JP; Carrero JJ; Lam NN; Molnar AO; Zimmerman D; McCallum MK; Garg AX; Sood MM
    Am J Kidney Dis; 2018 Feb; 71(2):191-199. PubMed ID: 29153994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tolerability of beta-blockers in outpatients with refractory heart failure who were receiving continuous milrinone.
    Earl GL; Verbos-Kazanas MA; Fitzpatrick JM; Narula J
    Pharmacotherapy; 2007 May; 27(5):697-706. PubMed ID: 17461705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.